Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December

Bulletin Express
Nov 07

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.

The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.

The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10